What is Congenital Adrenal Hyperplasia (CAH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Adrenal hyperplasia requires prompt diagnosis and treatment with glucocorticoid replacement therapy to prevent adrenal crisis and long-term complications. The most common form of adrenal hyperplasia is congenital adrenal hyperplasia (CAH), which affects approximately 1 in 15,000 live births 1. Treatment for CAH typically involves hydrocortisone as the first-line medication, with doses ranging from 10-15 mg/m² per day divided into 2-3 doses.

Key Considerations

  • For adults, alternative glucocorticoids such as prednisone (3-5 mg daily) or dexamethasone (0.25-0.5 mg daily) may be used 1.
  • Mineralocorticoid replacement with fludrocortisone (0.05-0.2 mg daily) is often necessary in salt-wasting forms of CAH.
  • Regular monitoring of hormone levels, growth in children, and bone density is crucial to prevent long-term complications such as infertility, osteoporosis, and metabolic disorders.
  • Stress dosing during illness or surgery is critical, typically requiring 2-3 times the normal dose to prevent adrenal crisis.

Management and Prevention

  • Patients with adrenal hyperplasia should wear medical alert identification and carry emergency hydrocortisone for injection in case of severe illness or trauma.
  • The goal of treatment is to replace deficient hormones while minimizing excess androgen production, allowing for normal growth and development in children and reducing the risk of long-term complications.
  • It is essential to note that all steroid-dependent patients, including those with adrenal hyperplasia, are at risk of adrenal crisis 1, highlighting the importance of careful management and monitoring.

From the Research

Adrenal Hyperplasia Overview

  • Adrenal hyperplasia, also known as congenital adrenal hyperplasia (CAH), is a genetic disorder that affects the adrenal glands [ 2 ].
  • CAH is caused by a deficiency of the 21-hydroxylase enzyme, which is necessary for the production of cortisol and aldosterone [ 3 ].
  • The condition can lead to a range of symptoms, including adrenal insufficiency, salt wasting, and an overproduction of androgens [ 4 ].

Treatment Options

  • The primary treatment for CAH is glucocorticoid replacement therapy, which aims to replace the lacking cortisol and aldosterone [ 3 ].
  • Different glucocorticoid replacement regimens are available, including hydrocortisone, prednisolone, and dexamethasone [ 3 ].
  • Novel treatments, such as modified-release hydrocortisone and continuous subcutaneous infusion of hydrocortisone, are being developed to improve the management of CAH [ 4 ].
  • These new treatments aim to replicate the natural cortisol rhythm and reduce the risk of long-term complications, such as gonadal dysfunction and cardiovascular disease [ 5 ].

Management of Adrenal Crisis

  • Adrenal crisis is a life-threatening condition that requires immediate treatment with glucocorticoids and fluid replacement [ 6 ].
  • The management of adrenal crisis involves stress adaptation and the use of emergency glucocorticoid kits [ 6 ].
  • European Reference Networks on rare endocrine conditions aim to harmonize treatment and ensure access to specialized patient care for individual case-by-case treatment decisions [ 6 ].

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.

The Cochrane database of systematic reviews, 2020

Research

Novel treatments for congenital adrenal hyperplasia.

Reviews in endocrine & metabolic disorders, 2022

Research

Current and future treatment options for adrenal insufficiency.

Current opinion in endocrinology, diabetes, and obesity, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.